Nature Aging· 2025Q1
Effect of the mitophagy inducer urolithin A on age-related immune decline: a randomized, placebo-controlled trial
- 39citations
- Q1SCImago
- 2025year
Short summary
A 4-week trial (n=50) found that urolithin A (UA) supplementation increased naive-like CD8+ T cells by 0.50 percentage points and boosted their fatty acid oxidation capacity by 14.72 percentage points compared to placebo.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openNutrition and DieteticsNursing